Amylin Pharmaceuticals to Present at Banc of America Healthcare Conference
May 24 2007 - 5:05PM
PR Newswire (US)
SAN DIEGO, May 24 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will be presenting at the Banc of America
Healthcare Conference on Wednesday, May 30, 2007 at 12:40 p.m. PT
in Las Vegas. Alice Bahner, Executive Director of Investor
Relations of Amylin Pharmaceuticals, will be providing a corporate
overview. The live presentation will be webcast, and a recording
will be made available following the event. The webcast and
recording will be accessible through Amylin's corporate website,
located at http://www.amylin.com/. To access the live webcast,
please log on to Amylin's site approximately fifteen minutes prior
to the presentation to register and download any necessary audio
software. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two
first-in-class medicines for diabetes, SYMLIN(R) (pramlintide
acetate) injection and BYETTA(R) (exenatide) injection. Amylin's
research and development activities leverage the company's
expertise in metabolism to develop potential therapies to treat
diabetes and obesity. Amylin is located in San Diego, California
with over 1,600 employees nationwide. For more information about
Amylin visit http://www.amylin.com/. DATASOURCE: Amylin
Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director,
Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024